DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/w4lz83/healthcare_regula) has announced the addition of GlobalData's new report "Healthcare, Regulatory and Reimbursement Landscape Russia" to their offering.
GlobalData, the industry analysis specialist, has released its new report, Healthcare, Regulatory and Reimbursement Landscape - Russia. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Russia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices markets. It is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.
Russia's population decreased at a CAGR of 0.1% between 2005 and 2010. As in most developed countries, the population contains a high proportion of elderly people, with approximately 13.2% of the population above the age of 65 years in 2010. The disease burden associated with this large elderly population is expected to boost growth in the pharmaceutical market, although hinder growth in the economy at the same time. Russia's pharmaceutical market is one of the fastest growing markets in the world, and was valued at approximately $18.7 billion in 2010, having grown at a CAGR of 23% from 2005. The medical device market is one of the most stable industries in the healthcare sector. The main segments in 2010 were diagnostic imaging, ophthalmic devices, cardiovascular devices, in vitro diagnostics and diabetes care devices.
The positive trends in the healthcare market can be attributed primarily to:
- Large elderly population
- Increased government spending
- Government initiatives focusing on the prevention and management of chronic diseases
- Government efforts to simplify regulatory guidelines
- Increased prevalence of non-communicable diseases
The report provides information on the healthcare, regulatory and reimbursement landscape, and its scope includes -
- Overview of the pharmaceutical and medical devices markets, including size, segmentation, and key drivers and barriers.
- Profiles and SWOT analysis of the major players in the pharmaceutical and medical device markets.
- Insightful review of the reimbursement and regulatory landscape, including details of the reimbursement process, regulatory agencies, and approval processes for new drugs and medical devices.
- A detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
- An overview of the opportunities for and challenges to growth in the healthcare market.
Reasons to buy
The report comprehensively covers both the pharmaceutical and the medical device markets. It will enhance your decision-making capability and allow you to:
- Develop business strategies by understanding the trends shaping and driving the healthcare market in Russia.
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, and pharmaceutical and medical devices market segments and companies likely to impact the healthcare market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of the main competitors.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnerships.
- Identify, understand and capitalize on the opportunities and challenges in the healthcare market.
For more information visit http://www.researchandmarkets.com/research/w4lz83/healthcare_regula